Association of Direct-Acting Antiviral Treatment with Mortality among Medicare Beneficiaries with Hepatitis C

Keyphrases

• Hepatitis C 100%
• Medicare Beneficiaries 100%
• Direct-acting Antiviral Treatment 100%
• Cirrhosis 52%
• Hazard Ratio 47%
• Propensity Score Matching 17%
• Direct-acting Antiviral Drugs 17%
• Direct-acting Antiviral Therapy 17%
• Hepatitis C Treatment 11%
• Dual Eligibles 11%
• Hepatitis C Virus Infection 11%
• Washout Period 11%
• Dual Eligibility 11%
• Non-dual 11%
• Dual-eligible Beneficiaries 11%
• Adjusted Hazard Ratio 11%
• Disease Progression 5%
• Medicare Claims Data 5%
• Expanded Access 5%
• Medicare Part D 5%
• Demographic Data 5%
• Mortality Rate 5%
• Population Health 5%
• Health Risk 5%
• Highly Effective 5%
• Reduced Mortality 5%
• Therapy Initiation 5%
• Survival Benefit 5%
• Separation Analysis 5%
• Time Since Death 5%
• Matched Cohort 5%
• Extended Life 5%
• Health Advantage 5%
• Demographic Indicators 5%
• Time-varying Exposure 5%
• 1-to-1 5%
• Cox Proportional Hazards Regression Model 5%

Medicine and Dentistry

• Medicare 100%
• Hepatitis C 100%
• Antiviral Therapy 100%
• Hazard Ratio 50%
• Liver Cirrhosis 45%
• Antiviral Drug 15%
• Cohort Analysis 10%
• Disease Exacerbation 5%
• Mortality Rate 5%
• Population Health 5%
• Proportional Hazards Model 5%
• Propensity Score Matching 5%
• Real-World Evidence 5%